Loading clinical trials...
Loading clinical trials...
This study is conducted in Japan. The aim of this study is to collect information about the efficacy and safety of Norditropin® (somatropin) in the long-term treatment of short stature with GHD (Growt...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novo Nordisk A/S
NCT07039084 · Genetic Disease, Nonverbal Communication, and more
NCT07348926 · Rare Genetic Disorders, Quality of Life, and more
NCT06725901 · Genetic Disease, Neurogenetic Disorders
NCT06898307 · Genetic Disease, Cardiac Disease, and more
NCT06362473 · Familial Hypercholesterolemia, Genetic Disorder
Tokyo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions